Nicotinell Tts 10

Nicotine, the active ingredient in Nicotinell Tts 10, is a nicotine replacement therapy presented as a 10 mg transdermal patch for transdermal use. It treats nicotine dependence and aids smoking cessation in adult smokers.

GNH USA supplies Nicotinell Tts 10 as a licensed, GDP-compliant international pharmaceutical supplier serving pharmacies and clinics worldwide.

Nicotinell Tts 10 is a nicotine replacement therapy used in the management of tobacco dependence.

- Smoking cessation: helps adult smokers reduce withdrawal symptoms and quit smoking. - Relapse prevention: supports maintenance of abstinence after quitting. - Adjunct to behavioral counseling: enhances the success of cessation programs when combined with counseling.

Common Side Effects: - Skin irritation at the application site - Itching or redness where the patch is applied - Headache - Nausea - Dizziness - Sleep disturbance (e.g., vivid dreams)

Serious or Rare Side Effects: - Allergic reaction such as rash, swelling, or hives - Severe skin necrosis or ulceration - Rapid heart rate (tachycardia) - Low blood pressure (hypotension) - Chest pain or palpitations

Before using Nicotinell Tts 10, consider the following precautions.

- Assess cardiovascular status: patients with recent heart attack or uncontrolled hypertension should use with caution. - Avoid use in non‑smokers: nicotine may cause dependence. - Do not apply to damaged or irritated skin: may increase systemic absorption. - Do not use concurrently with other nicotine products: risk of nicotine overdose. - Store at room temperature: keep in the original pouch, protect from moisture and heat.

Nicotinell Tts 10 may interact with other medicines; review the following.

Major Interactions (Avoid): - Concomitant use of monoamine oxidase inhibitors (MAOIs): may increase nicotine effects. - Use with other nicotine replacement products: risk of nicotine toxicity. - Concurrent use of certain antihypertensives (beta‑blockers): may cause additive hypotensive effect.

Moderate Interactions (Monitor Closely): - CYP2A6 inhibitors (e.g., methoxsalen): may reduce nicotine metabolism. - Alcohol consumption: may increase nicotine cravings. - Use with psychiatric medications (e.g., antipsychotics): may require monitoring for mood changes.